Evidence map›Paper›PMID 42940003›Full record

ArticleBiomedicines2026

Imatinib Resistance in Chronic Myeloid Leukemia Is Associated with Distinct Metabolic, Oxidative, and Autophagic Adaptations in K562-Derived Cell Sublines.

Ezzahra Rachid, Meriem Lahmouad, Rawane Bellemrrabet, Youssef Aboussaleh, Loubna Amahdar, Oualid Abboussi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ezzahra RachidScience & Engineering of Biomedicals, Biophysics and Health Laboratory, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26002, Morocco.ORCID 0009-0008-3171-319X
Meriem LahmouadBiology and Health Laboratory, Department of Life Sciences, Faculty of Sciences, University Ibn Tofail, B.P. 133, Kenitra 14000, Morocco.
Rawane BellemrrabetScience & Engineering of Biomedicals, Biophysics and Health Laboratory, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26002, Morocco.
Youssef AboussalehBiology and Health Laboratory, Department of Life Sciences, Faculty of Sciences, University Ibn Tofail, B.P. 133, Kenitra 14000, Morocco.
Loubna AmahdarScience & Engineering of Biomedicals, Biophysics and Health Laboratory, Higher Institute of Health Sciences, Hassan First University of Settat, Settat 26002, Morocco.ORCID 0000-0001-9069-9158
Oualid AbboussiPhysiology and Physiopathology Team, Faculty of Sciences, Mohammed V University in Rabat, Rabat 10000, Morocco.ORCID 0000-0002-9370-9435

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autophagychronic myeloid leukemiaglycolysisimatinib resistancemetabolic reprogrammingoxidative phosphorylationoxidative stressreactive oxygen species

Identifiers

PMID42940003
PMCPMC13701561

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.